Back to ASND
Vestal Point Capital, LP → ASND
Vestal Point Capital, LP ASND Position History
Ascendis Pharma A/S • Healthcare
Quarters held
4
Latest value
$168.6M
Q3 2026
Peak value
$168.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $37.3M |
| Q1 2026 | $85.8M |
| Q2 2026 | $100M |
| Q3 2026 | $168.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $168.6M | 740.0K | — | — |
| Q2 2026 | $100M | 375.0K | — | — |
| Q1 2026 | $85.8M | 375.0K | — | — |
| Q4 2025 | $37.3M | 175.0K | — | — |